Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “New Onset Diabetes Mellitus After Renal Transplantation”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Post-approval studies (Phase 4)Study completedNCT01683331
What this trial is testing

A Clinical Trial to Prevent New Onset Diabetes After Transplantation

Who this might be right for
Prevention of New Onset Diabetes Among Kidney Transplant Patients
University of Michigan 251
Large-scale testing (Phase 3)UnknownNCT02849899
What this trial is testing

Prevention of Diabetes After Transplantation by Vildagliptin in the Early Post-transplant Period

Who this might be right for
Disorder Related to Renal TransplantationDiabetes
Centre Hospitalier Universitaire de Besancon 186
Post-approval studies (Phase 4)Study completedNCT02083991
What this trial is testing

Trial of Steroid Avoidance and Low-dose CNI by ATG-induction in Renal Transplantation

Who this might be right for
Diabetes Mellitus
Vastra Gotaland Region 224
Testing effectiveness (Phase 2)Study completedNCT05240274
What this trial is testing

The POWERED Study: Prophylaxis With Metformin to Prevent PTDM

Who this might be right for
Post-transplant Diabetes MellitusNew Onset Diabetes After TransplantNew Onset Diabetes After Transplantation+4 more
Barts & The London NHS Trust 60
Post-approval studies (Phase 4)UnknownNCT02036554
What this trial is testing

Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft Recipients

Who this might be right for
Kidney; Complications, Allograft
Seoul St. Mary's Hospital 234
Post-approval studies (Phase 4)Ended earlyNCT03642184
What this trial is testing

Efficacy and Safety of Empagliflozin in NODAT

Who this might be right for
New Onset Diabetes After TransplantKidney Transplant; Complications
RenJi Hospital 6
Post-approval studies (Phase 4)Study completedNCT00171496
What this trial is testing

Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients

Who this might be right for
Kidney Transplant
Novartis 693
Post-approval studies (Phase 4)Ended earlyNCT01963728
What this trial is testing

Comparison of Insulin Therapy in Treating Post-Transplant Diabetes

Who this might be right for
Diabetes Mellitus
Inova Health Care Services 2
Not applicableStudy completedNCT01265537
What this trial is testing

A Pilot Study Comparing the Use of Low-target Versus Conventional Target Advagraf

Who this might be right for
Acute Graft RejectionDiabetes
University of British Columbia 30
Post-approval studies (Phase 4)Ended earlyNCT00936663
What this trial is testing

Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation

Who this might be right for
Type 2 DiabetesEnd Stage Renal Disease
University of Nebraska 3
Testing effectiveness (Phase 2)Ended earlyNCT01268995
What this trial is testing

Improving Secretion of Insulin in New Onset Diabetes After Renal Transplantation

Who this might be right for
New Onset Diabetes Mellitus After Renal Transplantation
Medical University of Vienna 32
Testing effectiveness (Phase 2)Study completedNCT00980356
What this trial is testing

Vildagliptin in New Onset Diabetes After Transplantation

Who this might be right for
Diabetes Mellitus
Medical University of Vienna 32
Post-approval studies (Phase 4)Study completedNCT01928199
What this trial is testing

Efficacy Study of Sitagliptin to Prevent New-onset Diabetes After Kidney Transplant

Who this might be right for
Posttransplant Diabetes Mellitus
Washington University School of Medicine 61
Large-scale testing (Phase 3)Study completedNCT03507829
What this trial is testing

Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients

Who this might be right for
Hyperglycemia
Medical University of Vienna 263
Post-approval studies (Phase 4)Ended earlyNCT01002339
What this trial is testing

Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After Transplantation

Who this might be right for
Diabetes Mellitus, Adult-Onset
Armando Torres Ramírez 134
Not applicableStudy completedNCT00442988
What this trial is testing

Prediction of NODAT After Renal Transplantation

Who this might be right for
Renal Transplantation
KU Leuven 360
Not applicableUnknownNCT06012799
What this trial is testing

Continuous Glucose Monitoring in Peri-operative Period in Kidney Transplant Recipients

Who this might be right for
New Onset Diabetes After Transplantation
Seoul National University Hospital 100
Not applicableStudy completedNCT04030013
What this trial is testing

"Outcome of Diabetes Education Among Renal Transplant Recipients With New Onset Diabetes After Transplantation (NODAT)"

Who this might be right for
New Onset Diabetes After TransplantDiabetes Mellitus
Dasman Diabetes Institute 210
Post-approval studies (Phase 4)UnknownNCT01875224
What this trial is testing

Comparison of NODAT in Kidney Transplant Patients Receiving Belatacept Versus Standard Immunosuppression

Who this might be right for
New Onset Diabetes After TransplantKidney Transplantation
University of Arizona 32
Post-approval studies (Phase 4)Study completedNCT01742624
What this trial is testing

Study to Evaluate the Safety and Efficacy of Advagraf vs Prograf in Kidney Transplantation Patients 1 Month After the Transplantation

Who this might be right for
de Novo Kidney Transplantation
Astellas Pharma Korea, Inc. 60